Details for: INLYTA
Company: PFIZER CANADA ULC
DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
---|---|---|---|---|---|
02389630 | INLYTA | AXITINIB | 1 MG | TABLET | ORAL |
02389649 | INLYTA | AXITINIB | 5 MG | TABLET | ORAL |
Summary Reports
Summary Basis of Decision
Summary Safety Review - Vascular Endothelial Growth Factor Receptor Inhibitors - Thrombotic Microangiopathy
Summary Safety Review - Vascular Endothelial Growth Factor Receptor Inhibitors - Thrombotic Microangiopathy
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.